Machine learning tool predicts cancer treatment response based on genetic mutations

A groundbreaking study led by USC Assistant Professor of Computer Science Ruishan Liu has uncovered how specific genetic mutations influence cancer treatment outcomes-insights that could help doctors tailor treatments more effectively.

Life sciences investor Decheng Capital targets $700M for fifth fund

After $900 million and $500-plus million fund closures last week from Foresite Capital and JP Morgan, respectively, another firm wants to enter the upper echelons

June 18, 2024

Fungal component may protect against flu-related lung damage

A component found in all fungi may provide a shield against flu-related lung damage, according to a new study.

February 18, 2025

Common cancer drug manufacturer warned by the FDA over data in India

Wracked with quality question marks that have caused major shortages of common cancer drugs, India-based generic drug manufacturer Intas Pharmaceuticals has been handed a warning

August 2, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.